Adjustment for Baseline Characteristics in Randomized Clinical Trials

Adjustment for Baseline Characteristics in Ra...

Up next

The Intention-to-Treat Principle: Assessing the True Effect of Choosing a Treatment With Dr Detry

Michelle A. Detry, PhD, Berry Consultants LLC, discusses The Intention-to-Treat Principle: How to Assess the True Effect of Choosing a Medical Treatment with JAMA Statistical Editor Roger J. Lewis, MD, PhD. Related Content: The Intention-to-Treat Principle 

Pattern-Mixture Models for Missing Data With Dr Little

Roderick Little, PhD, University of Michigan School of Public Health Departments of Epidemiology & Biostatistics discusses Pattern-Mixture Models for Missing Data with Roger J. Lewis, MD, PhD, statistical editor for JAMA. Related Content: Pattern-Mixture Models for Missing Data 

Recommended Episodes

Patient-Reported Outcomes in Clinical Trials
JAMA Clinical Reviews

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...

  Show more

PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
APTA Podcasts

In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multicom ...  Show more

Using Real-World Studies to Compare DMTs in MS
The ECTRIMS Podcast

Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, and Maria Pia Sormani, Professor of Biostatistics at the University of Genoa, discuss the use of real-world data to compare disease-modifying treatments (DMTs) in multiple sclerosis, inclu ...  Show more

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
JAMA Ophthalmology Author Interviews

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more